Evaluation of patients' care pathway before the first consultation in the radiotherapy department of Centre Hospitalier Nganda (Kinshasa) for breast cancer treatment

Introduction: That study assesses the care pathway to detect the reasons why the patients reached the radiotherapy department of Centre Hospitalier Nganda with advanced breast cancer. Material and Methods: We conducted a descriptive and analytical cross-sectional study from March 2024 to June 2024. We included all new breast cancer patients in our center. A p-value ≤ 0.05 was considered statistically significant for all analyses. An average comparison between quantitative variables was performed using the non-parametric Kruskal-Wallis test. Results and discussion: We enrolled 54 patients. The mean age was 53.13 ± 11.94 years and the median age was 51 years. A breast mass dominated the clinical picture in 87.07% of cases. Regarding the first medical contact, 77.78% of patients sought care in a conventional medical center. During the treatment, 31.48% of patients had received traditional pharmacopeia and 16.67% had undergone holistic treatment. Regarding radiotherapy indications, 14.81% of patients had no relevant indication for irradiation. The average time between the first symptoms and the radiotherapy consultation was 12.9 ± 9.2 months. There was a statistically significant positive correlation between the time from first symptoms to radiotherapy consultation and the staging of the disease (P-value=0.023). Patients who sought care at home (OR: 1.1; 95% CI 0.13-6.89) or in a conventional medical center (OR: 1.49; 95% CI 0.35-7.77) were all at risk of reaching radiotherapy with an advanced disease. Conclusion: The care pathway of breast cancer patients has a global impact on the outcome and also on the prognosis.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-30
DOI
https://doi.org/10.5281/zenodo.15128754
Primary Topic
Advances in Oncology and Radiotherapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of patients' care pathway before the first consultation in the radiotherapy department of Centre Hospitalier Nganda (Kinshasa) for breast cancer treatment

Zenodo (CERN European Organization for Nuclear Research)
Advances in Oncology and Radiotherapy
article

Evaluation of patients' care pathway before the first consultation in the radiotherapy department of Centre Hospitalier Nganda (Kinshasa) for breast cancer treatment

article en

Abstract

Introduction: That study assesses the care pathway to detect the reasons why the patients reached the radiotherapy department of Centre Hospitalier Nganda with advanced breast cancer. Material and Methods: We conducted a descriptive and analytical cross-sectional study from March 2024 to June 2024. We included all new breast cancer patients in our center. A p-value ≤ 0.05 was considered statistically significant for all analyses. An average comparison between quantitative variables was performed using the non-parametric Kruskal-Wallis test. Results and discussion: We enrolled 54 patients. The mean age was 53.13 ± 11.94 years and the median age was 51 years. A breast mass dominated the clinical picture in 87.07% of cases. Regarding the first medical contact, 77.78% of patients sought care in a conventional medical center. During the treatment, 31.48% of patients had received traditional pharmacopeia and 16.67% had undergone holistic treatment. Regarding radiotherapy indications, 14.81% of patients had no relevant indication for irradiation. The average time between the first symptoms and the radiotherapy consultation was 12.9 ± 9.2 months. There was a statistically significant positive correlation between the time from first symptoms to radiotherapy consultation and the staging of the disease (P-value=0.023). Patients who sought care at home (OR: 1.1; 95% CI 0.13-6.89) or in a conventional medical center (OR: 1.49; 95% CI 0.35-7.77) were all at risk of reaching radiotherapy with an advanced disease. Conclusion: The care pathway of breast cancer patients has a global impact on the outcome and also on the prognosis.

Zenodo (CERN European Organization for Nuclear Research)
Université de Yaoundé I (CM), University of Douala (CM)
Good health and well-being
Openalex Percentile: Top 52%
Advances in Oncology and Radiotherapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evaluation of patients' care pathway before the first consultation in the radiotherapy department of Centre Hospitalier Nganda (Kinshasa) for breast cancer treatment · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS